Thus, in the context of EML4-ALK+ NSCLC, ectopic expression of the EML4-ALK fusion protein is conferred by the EML4 gene promoter as the 5’ fusion partner gene [123]. This evidence concerns the gene EML4 and non-small cell lung carcinoma.